RNA-based therapeutics

Intervention1 paper1 finding

Outcomes

1

Lipoprotein

downin humans1

1 study

  1. RNA-based therapeutics decrease lipoprotein in humans (up to 80-90%).

    Review

    Lipoprotein(a) in cardiovascular disease: pathophysiology, residual risk, and emerging therapeutic strategies · Frontiers in medicine · 11 Aug 2026

Lipoprotein →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01

Related